Multinationals mull over investing in production in Russia
This article was originally published in Scrip
Executive Summary
Members of the Moscow-based Association of International Pharmaceutical Manufacturers (AIPM) are evaluating up to $1 billion in joint investment in local production, Jostein Davidsen, director general of Nycomed Russia-CIS, told the recent Adam Smith Conferences' 15th Annual International Russian Pharmaceutical Forum in St Petersburg. He said that AIPM has established a task force and drafted a position paper.